Literature DB >> 1562548

Biological effects of glucocorticoid hormones on two rat colon adenocarcinoma cell lines.

M G Denis1, C Chadéneau, P Blanchardie, P Lustenberger.   

Abstract

Glucocorticoid hormones are thought to play a role in carcinogenesis as they regulate cell differentiation and proliferation. We have investigated the effect of dexamethasone on two cell lines derived from a colon carcinoma, which differ by their tumorigenicity. Dexamethasone was found to inhibit growth of both the progressive (PROb) and the regressive clone (REGb). Upon glucocorticoid treatment, PROb cells were found to secrete an additional Mr approximately 40,000 protein. The synthesis and the release in the culture medium of this protein is stimulated specifically by glucocorticoid agonists, and not by other steroid hormones. The anti-glucocorticoid RU 38486 is inefficient and suppresses the induction of this protein by dexamethasone. Induction is sensitive to actinomycin D, suggesting that regulation may be related to an alteration of the rate of mRNA synthesis. The cellular effect of glucocorticoid hormones being mediated through a specific soluble receptor, we have characterized this protein. The PROb cells contained more specific glucocorticoid-binding sites (approximately 170,000 sites per cell) than the regressive ones (REGb cells; approximately 100,000 sites per cell). In both clones, the receptor was associated with the Mr approximately 90,000 heat shock protein to yield large complexes (Stokes radius Rs approximately 7.5 nm), which were dissociated to the same extent upon heat- and salt-treatment. The steroid- and DNA-binding unit of the receptor, characterized under denaturing conditions using an anti-receptor monoclonal antibody, was found to be more degraded in the PROb cell line.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562548     DOI: 10.1016/0960-0760(92)90415-f

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  4 in total

1.  Epithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis.

Authors:  Li Jiang; Shilin Yang; Huiyong Yin; Xiaofeng Fan; Suwan Wang; Bing Yao; Ambra Pozzi; Xiaoping Chen; Raymond C Harris; Ming-Zhi Zhang
Journal:  Mol Cancer Res       Date:  2013-06-05       Impact factor: 5.852

2.  Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans.

Authors:  Ming-Zhi Zhang; Jie Xu; Bing Yao; Huiyong Yin; Qiuyin Cai; Martha J Shrubsole; Xiwu Chen; Valentina Kon; Wei Zheng; Ambra Pozzi; Raymond C Harris
Journal:  J Clin Invest       Date:  2009-03-23       Impact factor: 14.808

3.  Inhibition of 11β-Hydroxysteroid Dehydrogenase Type II Suppresses Lung Carcinogenesis by Blocking Tumor COX-2 Expression as Well as the ERK and mTOR Signaling Pathways.

Authors:  Jian Chang; Min Xue; Shilin Yang; Bing Yao; Bixiang Zhang; Xiaoping Chen; Ambra Pozzi; Ming-Zhi Zhang
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

4.  A transition in transcriptional activation by the glucocorticoid and retinoic acid receptors at the tumor stage of dermal fibrosarcoma development.

Authors:  M D Vivanco; R Johnson; P E Galante; D Hanahan; K R Yamamoto
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.